Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mediwound Ltd Ord Sh
(NQ:
MDWD
)
17.83
-0.51 (-2.78%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mediwound Ltd Ord Sh
< Previous
1
2
3
4
5
Next >
MediWound to Report First Quarter 2023 Financial Results
May 12, 2023
Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces an Additional $10 Million Award from BARDA
May 09, 2023
Funding to support emergency stockpiling replenishment, pediatric indication submission, and expanded access treatment protocol extension
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023
April 26, 2023
From
MediWound Ltd.
Via
GlobeNewswire
5 Analysts Have This to Say About MediWound
March 17, 2023
Via
Benzinga
Preview: MediWound's Earnings
March 15, 2023
Via
Benzinga
Cowen & Co. Maintains Outperform Rating for MediWound: Here's What You Need To Know
December 30, 2022
Via
Benzinga
FDA Approves MediWound's NexoBrid For Burn Treatment
December 30, 2022
Via
Benzinga
MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update
March 16, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer
March 16, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth
March 06, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Fourth Quarter and Year-End 2022 Financial Results
March 02, 2023
Conference Call and Webcast Scheduled for Thursday, March 16 at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present Corporate Highlights at Upcoming Investor Conferences
February 23, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares
February 07, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market
February 03, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Starbucks To Rally 11%? Here Are 10 Other Analyst Forecasts For Wednesday
January 04, 2023
UBS cut Microsoft Corporation (NASDAQ: MSFT) price target from $300 to $250. UBS analyst Karl Keirstead downgraded the stock from Buy to Neutral. Microsoft shares fell 2% to $234.73 in pre-market...
Via
Benzinga
MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
December 29, 2022
From
MediWound Ltd.
Via
GlobeNewswire
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
MediWound Expands NexoBrid’s Global Presence with Marketing Approval in Japan
December 23, 2022
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Strengthens European Presence of NexoBrid®
December 20, 2022
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
December 19, 2022
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Expands Global Presence as NexoBrid® Gains Approval in India
December 13, 2022
Exclusive marketing and distribution agreement signed with Bharat Serum and Vaccines Limited (BSV), a leading biopharmaceutical company
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces a 1-for-7 Reverse Share Split
December 05, 2022
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For November 15, 2022
November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
Via
Benzinga
MediWound to Report Third Quarter 2022 Financial Results
November 03, 2022
Conference Call and Webcast Scheduled for Tuesday, November 15, 2022 at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Formation of Strategic Advisory Board
October 25, 2022
Esteemed group of industry leaders to contribute expertise and experience to MediWound’s strategic and operational activities
From
MediWound Ltd.
Via
GlobeNewswire
MediWound's EscharEx® Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022
October 18, 2022
EscharEx’s promising results from the completed Phase 2 trials were highlighted
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings
October 07, 2022
Gross Proceeds of $30.5 Million Raised
From
MediWound Ltd.
Via
GlobeNewswire
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Gainers
Via
Benzinga
Dow Turns Higher; Crude Oil Rises 0.7%
September 22, 2022
U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday.
Via
Benzinga
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
September 22, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.